Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-03

Clinical Trial Update: Effectiveness of Port Site Bupivacaine Injection in Postoperative Pain Reduction After Lap. Chole [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigates the effectiveness of port-site bupivacaine injection in reducing postoperative pain after laparoscopic cholecystectomy; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)

Snippet

Sponsor: Hamdard University | Conditions: Pain, Postoperative | Phase 3 | Status: UNKNOWN